UBS AM’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-6,520
| Closed | -$37K | – | 2688 |
|
|
2016
Q1 | $37K | Sell |
6,520
-30,973
| -83% | -$176K | ﹤0.01% | 2621 |
|
|
2015
Q4 | $645K | Sell |
37,493
-83,392
| -69% | -$1.43M | ﹤0.01% | 1911 |
|
|
2015
Q3 | $2.55M | Sell |
120,885
-48,270
| -29% | -$1.02M | ﹤0.01% | 1314 |
|
|
2015
Q2 | $8.37M | Buy |
169,155
+1,250
| +0.7% | +$61.9K | 0.01% | 937 |
|
|
2015
Q1 | $13.1M | Buy |
167,905
+1,800
| +1% | +$141K | 0.01% | 807 |
|
|
2014
Q4 | $10.1M | Hold |
166,105
| – | – | 0.01% | 864 |
|
|
2014
Q3 | $7.08M | Sell |
166,105
-16,050
| -9% | -$684K | 0.01% | 953 |
|
|
2014
Q2 | $11.3M | Buy |
182,155
+3,500
| +2% | +$216K | 0.01% | 813 |
|
|
2014
Q1 | $11.6M | Buy |
178,655
+37,900
| +27% | +$2.46M | 0.01% | 801 |
|
|
2013
Q4 | $7.92M | Sell |
140,755
-16,555
| -11% | -$932K | 0.01% | 889 |
|
|
2013
Q3 | $9.66M | Buy |
157,310
+48,480
| +45% | +$2.98M | 0.01% | 812 |
|
|
2013
Q2 | $6.37M | Buy |
+108,830
| New | +$6.37M | 0.01% | 896 |
|